SECURE 340B Act

Sponsor: Scott H. Peters (Democratic-CA)July 6, 2026

AI-generated ?

Report an error

Introduced

In Committee

Passed One Chamber

Passed Both Chambers

Signed into Law

Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Requires drug discount program to improve patient drug prices, increase transparency, and boost oversight.

This bill would change the rules for the 340B drug discount program, which helps certain hospitals and clinics buy medicines at lower prices. It would make sure more of these savings reach patients through financial assistance and clear pricing. The bill also adds new ways to track drug discounts and prevent fraud, while stopping health plans from discriminating against these hospitals and pharmacies.

What Would Change

Today, rules for who counts as a 340B patient, how contract pharmacies operate, and how hospitals offer financial aid can vary or be unclear. Hospitals may also have fewer restrictions on debt collection. After this bill, there would be clear, nationwide definitions for 340B patients and child sites, strict rules for contract pharmacies, and mandatory financial assistance policies for low-income patients. Certain hospitals would be banned from aggressive debt collection, and a new data system would track drug discounts to prevent fraud.

Key Provisions

Defines who counts as a "patient" eligible for discounted drugs, requiring recent care and auditable records.
Requires hospitals and clinics to offer financial assistance and sliding scale drug prices to more low-income patients.
Bans certain hospitals from selling patient debt, reporting it to credit agencies, or denying care for unpaid bills.
Requires drug manufacturers to offer discounts to hospitals using contract pharmacies and stops health plans from discriminating against these pharmacies.
Creates a new national system to track drug sales and prevent duplicate discounts or misuse of the program.
Requires hospitals and clinics to report how they use their drug discount savings to benefit patients and communities.

View on Congress.gov

HR 9599 · 119th Congress · July 6, 2026 · AI Summary by gemini-2.5-flash · 9/10

SECURE 340B Act

What Would Change

Key Provisions

Lobbying Activity